Wogonin potentiates cisplatin-induced cancer cell apoptosis through accumulation of intracellular reactive oxygen species

Oncology Reports

Volumn 28, Issue 2, 2012, Pages 601-605

  He, Fan ^a   Wang, Qiong ^a   Zheng, Xue Lian ^a   Yan, Jia Qi ^a   Yang, Lan ^a   Sun, Hong ^a   Hu, Li Na ^a   Lin, Yong ^a   Wang, Xia ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Apoptosis; Cisplatin; Reactive oxygen species; Wogonin

Indexed keywords

ACETYLCYSTEINE; BUTYLATED HYDROXYANISOLE; CASPASE 3; CISPLATIN; HYDROGEN PEROXIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; REACTIVE OXYGEN METABOLITE; WOGONIN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER COMBINATION CHEMOTHERAPY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DRUG POTENTIATION; ENZYME ACTIVATION; FEMALE; HELA CELL; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; PRIORITY JOURNAL; PROTEIN CLEAVAGE; UTERINE CERVIX CANCER;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APOPTOSIS; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; CISPLATIN; DRUG SYNERGISM; FEMALE; FLAVANONES; HELA CELLS; HUMANS; MALE; REACTIVE OXYGEN SPECIES; UTERINE CERVICAL NEOPLASMS;

EID: 84863447212     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2012.1841     Document Type: Article

References (24)

1. Cohen SM and Lippard SJ: Cisplatin: from DNA damage to cancer chemotherapy. Prog Nucleic Acid Res Mol Biol 67: 93-130, 2001. (Pubitemid 33804642)
2. Siddik ZH: Cisplatin: mode of cytotoxic action and molecular basis of resistance. Oncogene 22: 7265-7279, 2003. (Pubitemid 37487159)
3. Niedner H, Christen R, Lin X, Kondo A and Howell SB: Identification of genes that mediate sensitivity to cisplatin. Mol Pharmacol 60: 1153-1160, 2001. (Pubitemid 33144883)
4. Chi YS, Lim H, Park H and Kim HP: Effects of wogonin, a plant flavone from Scutellaria radix, on skin inflammation: in vivo regulation of inflammation-associated gene expression. Biochem Pharmacol 66: 1271-1278, 2003. (Pubitemid 37130302)
5. 2 induced liver injury. Eur J Pharmacol 536: 192-199, 2006.
6. Ma SC, Du J, But PP, Deng XL, Zhang YW, Ooi VE, Xu HX, Lee SH and Lee SF: Antiviral chinese medicinal herbs against respiratory syncytial virus. J Ethnopharmacol 79: 205-211, 2002. (Pubitemid 34136952)
7. Lee DH, Kim C, Zhang L and Lee YJ: Role of p53, PUMA, and Bax in wogonin-induced apoptosis in human cancer cells. Biochem Pharmacol 75: 2020-2033, 2008.
8. Baumann S, Fas SC, Giaisi M, Muller WW, Merling A, Gulow K, Edler L, Krammer PH and Li-Weber M: Wogonin preferentially kills malignant lymphocytes and suppresses T-cell tumor growth by inducing PLCγ1- and Ca2+-dependent apoptosis. Blood 111: 2354-2363, 2008. (Pubitemid 351451444)
9. Enomoto R, Koshiba C, Suzuki C and Lee E: Wogonin potentiates the antitumor action of etoposide and ameliorates its adverse effects. Cancer Chemother Pharmacol 67: 1063-1072, 2011.
10. Lee E, Enomoto R, Koshiba C and Hirano H: Inhibition of P-glycoprotein by wogonin is involved with the potentiation of etoposide-induced apoptosis in cancer cells. Ann NY Acad Sci 1171: 132-136, 2009.
11. Wang HW, Lin CP, Chiu JH, Chow KC, Kuo KT, Lin CS and Wang LS: Reversal of inflammation-associated dihydrodiol dehydrogenases (AKR1C1 and AKR1C2) overexpression and drug resistance in non-small cell lung cancer cells by wogonin and chrysin. Int J Cancer 120: 2019-2027, 2007.
12. Lee DH, Rhee JG and Lee YJ: Reactive oxygen species up-regulate p53 and Puma; a possible mechanism for apoptosis during combined treatment with TRAIL and wogonin. Br J Pharmacol 157: 1189-1202, 2009.
13. Yang L, Zheng XL, Sun H, Zhong YJ, Wang Q, He HN, Shi XW, Zhou B, Li JK, Lin Y, et al: Catalase suppression-mediated H(2)O(2) accumulation in cancer cells by wogonin effectively blocks tumor necrosis factor-induced NF-κB activation and sensitizes apoptosis. Cancer Sci 102: 870-876.
14. Wang X, Ju W, Renouard J, Aden J, Belinsky SA and Lin Y: 17-Allylamino-17-demethoxygeldanamycin synergistically potentiates tumor necrosis factor-induced lung cancer cell death by blocking the nuclear factor-κB pathway. Cancer Res 66: 1089-1095, 2006. (Pubitemid 43165977)
15. Ju W, Wang X, Shi H, Chen W, Belinsky SA and Lin Y: A critical role of luteolin-induced reactive oxygen species in blockage of tumor necrosis factor-activated nuclear factor-κB pathway and sensitization of apoptosis in lung cancer cells. Mol Pharmacol 71: 1381-1388, 2007. (Pubitemid 46658691)
16. Fas SC, Baumann S, Zhu JY, Giaisi M, Treiber MK, Mahlknecht U, Krammer PH and Li-Weber M: Wogonin sensitizes resistant malignant cells to TNFα- and TRAIL-induced apoptosis. Blood 108: 3700-3706, 2006. (Pubitemid 44864547)
17. Galati G and O'Brien PJ: Potential toxicity of flavonoids and other dietary phenolics: significance for their chemopreventive and anticancer properties. Free Radic Biol Med 37: 287-303, 2004. (Pubitemid 38833996)
18. Lin Y, Shi R, Wang X and Shen HM: Luteolin, a flavonoid with potential for cancer prevention and therapy. Curr Cancer Drug Targets 8: 634-646, 2008.
19. Cao G, Sofic E and Prior RL: Antioxidant and prooxidant behavior of flavonoids: structure-activity relationships. Free Radic Biol Med 22: 749-760, 1997. (Pubitemid 27058337)
20. Sugihara N, Arakawa T, Ohnishi M and Furuno K: Anti- and pro-oxidative effects of flavonoids on metal-induced lipid hydroperoxide-dependent lipid peroxidation in cultured hepatocytes loaded with α-linolenic acid. Free Radic Biol Med 27: 1313-1323, 1999. (Pubitemid 30001494)
21. Gordaliza M, Garcia PA, del Corral JM, Castro MA and Gomez-Zurita MA: Podophyllotoxin: distribution, sources, applications and new cytotoxic derivatives. Toxicon 44: 441-459, 2004. (Pubitemid 39070644)
22. Hildeman DA, Mitchell T, Aronow B, Wojciechowski S, Kappler J and Marrack P: Control of Bcl-2 expression by reactive oxygen species. Proc Natl Acad Sci USA 100: 15035-15040, 2003. (Pubitemid 37518012)
23. Wang L, Chanvorachote P, Toledo D, Stehlik C, Mercer RR, Castranova V and Rojanasakul Y: Peroxide is a key mediator of Bcl-2 down-regulation and apoptosis induction by cisplatin in human lung cancer cells. Mol Pharmacol 73: 119-127, 2008. (Pubitemid 350294203)
24. Tenopoulou M, Doulias PT, Barbouti A, Brunk U and Galaris D: Role of compartmentalized redox-active iron in hydrogen peroxide-induced DNA damage and apoptosis. Biochem J 387: 703-710, 2005. (Pubitemid 40685704)